NRC-2023-0174, Comment (1) of Anonymous Individual on Accelerated Decommissioning Partners Crystal River Unit 3, LLC; Crystal River Unit 3; License Termination Plan

From kanterella
(Redirected from NRC-2023-0174)
Jump to navigation Jump to search
Comment (1) of Anonymous Individual on Accelerated Decommissioning Partners Crystal River Unit 3, LLC; Crystal River Unit 3; License Termination Plan
ML24074A464
Person / Time
Site: Crystal River Duke Energy icon.png
Issue date: 03/07/2024
From:
- No Known Affiliation
To:
Office of Administration
References
NRC-2023-0174, 88FR77111 00001
Download: ML24074A464 (1)


Text

3/14/24, 9 57 AM blob https //www fdms gov/53a21d90 1501 46ef b515 4ace53e81835 blob https //www fdms gov/53a21d90 1501 46ef b515 4ace53e81835 1/1 PUBLIC SUBMISSION As of: 3/14/24, 9:56 AM Received: March 07, 2024 Status: Pending Post Tracking No. lth-js64-u3jw Comments Due: March 07, 2024 Submission Type: Web Docket: NRC-2023-0174 Accelerated Decommissioning Partners Crystal River Unit 3, LLC; Crystal River Unit 3; License Termination Plan Comment On: NRC-2023-0174-0001 Accelerated Decommissioning Partners Crystal River Unit 3, LLC; Crystal River Unit 3 Nuclear Generating Plant; License Termination Plan Document: NRC-2023-0174-DRAFT-0001 Comment on FR Doc # 2023-24620 Submitter Information Name: Anonymous Anonymous Email:

General Comment The staff assigned within ADPCR3 have limited experience with the current methodologies for performing the radiological dose calculations associated with a License Termination. This is apparent from the limited detail on how the calculations will be performed that has been provided to date in licensee submittals. Recent License Terminations at Zion, LaCrosse, and Humboldt Bay have shown that without the appropriate level of analytical experience on staff that the process and time required to complete this work can extend the total time to terminate a license by many years. The ADPCR3 staff has limited experience with collecting radiological samples but no recent experience with performing the calculations required to demonstrate that the final dose will comply with the 10 CFR 20.1402 dose limit.

SUNSI Review Complete Template=ADM-013 E-RIDS=ADM-03 ADD: Tim Barvitskie, Jack Parrott, Sarah Achten, Mary Neely Comment (1)

Publication Date: 11/8/2023 Citation: 88 FR 77111